These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17217711)

  • 41. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
    Liberopoulos E; Christides D; Elisaf M
    J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG; Mateos F; Buño A; Ortega R; Rodriguez F; Dal-Ré R
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serum uric acid prevalence and changes post various antihypertensive agents in patients with essential hypertension].
    Chen H; Yang LQ; Yu L; Wu XY; Lu LH; Gui W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):523-6. PubMed ID: 19100066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.
    Kim HS; Kim H; Lee SH; Kim JH
    J Clin Pharm Ther; 2020 Dec; 45(6):1264-1270. PubMed ID: 32737930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials.
    Smink PA; Bakker SJ; Laverman GD; Berl T; Cooper ME; de Zeeuw D; Lambers Heerspink HJ
    J Hypertens; 2012 May; 30(5):1022-8. PubMed ID: 22388234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CYP2C9 Ile359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensive patients.
    Chen G; Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Xing H; Wang B; Yu Y; Xu X
    Methods Find Exp Clin Pharmacol; 2006; 28(1):19-24. PubMed ID: 16541193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of irbesartan on left ventricular mass and arterial stiffness in hypertensive patients.
    Park CG; Ahn JC; Hong SJ; Kim EJ; Lee SJ; Park SM; Seo HS; Oh DJ
    Korean J Intern Med; 2006 Jun; 21(2):103-8. PubMed ID: 16913439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial.
    Salcedo-Alejos M; Banda-Espinoza F; Rodríguez-Morán M; Guerrero-Romero F
    Nephrol Dial Transplant; 2005 Oct; 20(10):2120-5. PubMed ID: 16091379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients.
    Peters CD; Kjaergaard KD; Jensen JD; Christensen KL; Strandhave C; Tietze IN; Novosel MK; Bibby BM; Jensen LT; Sloth E; Jespersen B
    Kidney Int; 2014 Sep; 86(3):625-37. PubMed ID: 24670413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study).
    Peters CD; Kjaergaard KD; Nielsen CH; Christensen KL; Bibby BM; Jensen JD; Jespersen B
    Hemodial Int; 2017 Jan; 21(1):47-62. PubMed ID: 27346437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
    Bunt T
    Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect between felodipine plus irbesartan and felodipine plus metoprolol regimen on the sexual function in young and middle-aged women with hypertension].
    Xu D; Yu J; Liu PJ; Guo XY; Hu H; Chang P; Zhao F; Li XL; Chen XH; Shen XP; Zhang Y; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):728-33. PubMed ID: 21055142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study.
    Sola S; Mir MQ; Cheema FA; Khan-Merchant N; Menon RG; Parthasarathy S; Khan BV
    Circulation; 2005 Jan; 111(3):343-8. PubMed ID: 15655130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of different combined antihypertensive regimen on the erectile function in male hypertensive patients].
    Yang LQ; Yu J; Ma RX; Liu PJ; Guo XY; Li XL; Chang P; Hu H; Zhao F; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):636-41. PubMed ID: 22088245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.
    Fan Y; Wei F; Lang Y; Wang S
    J Hypertens; 2015 Apr; 33(4):681-8; discussion 689. PubMed ID: 25915869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.
    Ah YM; Lee JY; Choi YJ; Kong J; Kim B; Choi KH; Han N; Yu YM; Oh JM; Shin WG; Lee HY
    Clin Exp Hypertens; 2016; 38(3):325-30. PubMed ID: 27028796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial.
    Hong KS; Kang DW; Bae HJ; Kim YK; Han MK; Park JM; Rha JH; Lee YS; Koo JS; Cho YJ; Kwon SU; Kim SE; Park SH
    Acta Neurol Scand; 2010 Jan; 121(1):51-7. PubMed ID: 19925528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.
    Bahlmann FH; de Groot K; Mueller O; Hertel B; Haller H; Fliser D
    Hypertension; 2005 Apr; 45(4):526-9. PubMed ID: 15767470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.